BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25105581)

  • 1. Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides.
    Prenner SB; Mulvey CK; Ferguson JF; Rickels MR; Bhatt AB; Reilly MP
    Atherosclerosis; 2014 Oct; 236(2):244-50. PubMed ID: 25105581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.
    Hopkins PN; Nanjee MN; Wu LL; McGinty MG; Brinton EA; Hunt SC; Anderson JL
    Atherosclerosis; 2009 Dec; 207(2):559-66. PubMed ID: 19524242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites.
    Martin SS; Qasim AN; Mehta NN; Wolfe M; Terembula K; Schwartz S; Iqbal N; Schutta M; Bagheri R; Reilly MP
    Diabetes; 2009 Aug; 58(8):1887-92. PubMed ID: 19491209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance.
    Martin SS; Qasim AN; Wolfe M; St Clair C; Schwartz S; Iqbal N; Schutta M; Bagheri R; Mehta NN; Rader DJ; Reilly MP
    Am J Cardiol; 2011 Feb; 107(3):393-8. PubMed ID: 21257004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum magnesium is inversely associated with coronary artery calcification in the Genetics of Atherosclerotic Disease (GEA) study.
    Posadas-Sánchez R; Posadas-Romero C; Cardoso-Saldaña G; Vargas-Alarcón G; Villarreal-Molina MT; Pérez-Hernández N; Rodríguez-Pérez JM; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG; Torres-Tamayo M
    Nutr J; 2016 Mar; 15():22. PubMed ID: 26931571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
    Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
    Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women.
    Qasim AN; Martin SS; Mehta NN; Wolfe ML; Park J; Schwartz S; Schutta M; Iqbal N; Reilly MP
    Int J Cardiol; 2011 Jul; 150(1):17-21. PubMed ID: 20303190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death.
    Takeichi S; Yukawa N; Nakajima Y; Osawa M; Saito T; Seto Y; Nakano T; Saniabadi AR; Adachi M; Wang T; Nakajima K
    Atherosclerosis; 1999 Feb; 142(2):309-15. PubMed ID: 10030382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery calcification at electron beam computed tomography is increased in asymptomatic type 2 diabetics independent of traditional risk factors.
    Wolfe ML; Iqbal N; Gefter W; Mohler ER; Rader DJ; Reilly MP
    J Cardiovasc Risk; 2002 Dec; 9(6):369-76. PubMed ID: 12478207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factor Interactions, Non-High-Density Lipoprotein Cholesterol to Apolipoprotein B Ratio, and Severity of Coronary Arteriosclerosis in South Asian Individuals: An Observational Cohort Study.
    Molina CR; Mathur A; Soykan C; Sathe A; Kunhiraman L
    J Am Heart Assoc; 2023 May; 12(10):e027697. PubMed ID: 37183833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes does not attenuate racial differences in coronary calcification.
    Wade AN; Fedyna S; Mehta NN; St Clair C; Ginwala N; Krishna RK; Qasim AN; Braunstein S; Iqbal N; Schutta MH; Reilly MP
    Diabetes Res Clin Pract; 2011 Jan; 91(1):101-7. PubMed ID: 21067835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes.
    Gunczler P; Lanes R; Soros A; Verdu L; Ramon Y; Guevara B; Beer N
    J Pediatr; 2006 Sep; 149(3):320-3. PubMed ID: 16939740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.